ArcherDX

About:

ArcherDX is a biotechnology firm specializing in cancer research.

Website: http://archerdx.com

Twitter/X: archerdxinc

Top Investors: Perceptive Advisors, Sands Capital Ventures, Qiagen, Redmile Group, Soleus Capital

Description:

ArcherDX is advancing molecular pathology with a robust technology platform for genetic mutation detection by next-generation sequencing. By combining proprietary Anchored Multiplexed PCR (AMP™) chemistry in an easy-to-use, lyophilized format and powerful bioinformatics software, the Archer® platform dramatically enhances genetic mutation identification and discovery. ArcherDX provides oncology-focused research products and is pursuing regulatory approval for multiple companion diagnostic assays.